Typhoid Fever - Pipeline Review, H2 2019

Global Markets Direct’s, ‘Typhoid Fever - Pipeline Review, H2 2019’, provides an overview of the Typhoid Fever pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Typhoid Fever, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Typhoid Fever and features dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the global therapeutic landscape of Typhoid Fever

- The report reviews pipeline therapeutics for Typhoid Fever by companies and universities/research institutes based on information derived from company and industry-specific sources

- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

- The report reviews key players involved Typhoid Fever therapeutics and enlists all their major and minor projects

- The report assesses Typhoid Fever therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

- The report summarizes all the dormant and discontinued pipeline projects

- The report reviews latest news related to pipeline therapeutics for Typhoid Fever

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of therapeutics under development for Typhoid Fever

- Identify potential new clients or partners in the target demographic

- Develop strategic initiatives by understanding the focus areas of leading companies

- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

- Devise corrective measures for pipeline projects by understanding Typhoid Fever pipeline depth and focus of Indication therapeutics

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Companies mentioned

Eubiologics Co Ltd

GlaxoSmithKline Plc

Indian Immunologicals Ltd

Ology Bioservices Inc

Prokarium Ltd

Protein Potential LLC

Sanofi Pasteur SA

Shantha Biotechnics Pvt Ltd

Walvax Biotechnology ...

Eubiologics Co Ltd

GlaxoSmithKline Plc

Indian Immunologicals Ltd

Ology Bioservices Inc

Prokarium Ltd

Protein Potential LLC

Sanofi Pasteur SA

Shantha Biotechnics Pvt Ltd

Walvax Biotechnology Co Ltd

Table of Contents

Table of Contents

List of Tables

List of Figures

Introduction

Global Markets Direct Report Coverage

Typhoid Fever - Overview

Typhoid Fever - Therapeutics Development

Pipeline ...

Table of Contents

List of Tables

List of Figures

Introduction

Global Markets Direct Report Coverage

Typhoid Fever - Overview

Typhoid Fever - Therapeutics Development

Pipeline Overview

Pipeline by Companies

Pipeline by Universities/Institutes

Products under Development by Companies

Products under Development by Universities/Institutes

Typhoid Fever - Therapeutics Assessment

Assessment by Target

Assessment by Route of Administration

Assessment by Molecule Type

Typhoid Fever - Companies Involved in Therapeutics Development

Eubiologics Co Ltd

GlaxoSmithKline Plc

Indian Immunologicals Ltd

Ology Bioservices Inc

Prokarium Ltd

Protein Potential LLC

Sanofi Pasteur SA

Shantha Biotechnics Pvt Ltd

Walvax Biotechnology Co Ltd

Typhoid Fever - Drug Profiles

(paratyphoid (bivalent) + typhoid) vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

(paratyphoid + typhoid) vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

(rotavirus (virus like particle) + typhiod) vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

(shigella + typhoid) (Bivalent) vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

(Streptococcal pneumonia + typhoid) vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

EUC-002 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

infectious disease vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Typhella - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

typhoid vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

typhoid vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

typhoid vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

typhoid vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

typhoid vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

typhoid vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

typhoid vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

typhoid Vi polysaccharide [strain S typhi Ty2] vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

ViCRM-197 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

ViCRM-197 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Typhoid Fever - Dormant Projects

Typhoid Fever - Discontinued Products

Typhoid Fever - Product Development Milestones

Featured News & Press Releases

Oct 08, 2012: Typhim Vi - Typhoid Polysaccharide Vaccine - antigen levels below required specification

Oct 05, 2012: Sanofi Pasteur Voluntarily Recalls Few Batches Of Typhoid Fever Vaccine

Jun 23, 2011: Sanofi Pasteur’s Typhim Vi Receives Prequalification From World Health Organization

Jun 05, 2008: Emergent BioSolutions Initiates U.S. Phase II Trial of Oral Typhoid Vaccine Candidate

Jan 08, 2008: Emergent BioSolutions Announces Final Phase II Clinical Study Results for Typhoid Vaccine

Nov 21, 2005: Emergent Biosolutions Starts Clinical Study Of Single-Dose Oral Typhoid Vaccine

Aug 30, 2005: Emergent Biosolutions' Typhoid Vaccine Achieves Positive Results In Phase II Clinical Study

Nov 29, 1994: Food And Drug Administration Grants License For A New Typhoid Fever Vaccine

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

List of Tables

Number of Products under Development for Typhoid Fever, H2 2019

Number of Products under Development by Companies, H2 2019

Number of Products ...

List of Tables

Number of Products under Development for Typhoid Fever, H2 2019

Number of Products under Development by Companies, H2 2019

Number of Products under Development by Universities/Institutes, H2 2019

Products under Development by Companies, H2 2019

Products under Development by Universities/Institutes, H2 2019

Number of Products by Stage and Target, H2 2019

Number of Products by Stage and Route of Administration, H2 2019

Number of Products by Stage and Molecule Type, H2 2019

Typhoid Fever - Pipeline by Eubiologics Co Ltd, H2 2019

Typhoid Fever - Pipeline by GlaxoSmithKline Plc, H2 2019

Typhoid Fever - Pipeline by Indian Immunologicals Ltd, H2 2019

Typhoid Fever - Pipeline by Ology Bioservices Inc, H2 2019

Typhoid Fever - Pipeline by Prokarium Ltd, H2 2019

Typhoid Fever - Pipeline by Protein Potential LLC, H2 2019

Typhoid Fever - Pipeline by Sanofi Pasteur SA, H2 2019

Typhoid Fever - Pipeline by Shantha Biotechnics Pvt Ltd, H2 2019

Typhoid Fever - Pipeline by Walvax Biotechnology Co Ltd, H2 2019

Typhoid Fever - Dormant Projects, H2 2019

Typhoid Fever - Discontinued Products, H2 2019

List of Figures

List of Figures

Number of Products under Development for Typhoid Fever, H2 2019

Number of Products under Development by Companies, H2 2019

Number of Products ...

List of Figures

Number of Products under Development for Typhoid Fever, H2 2019

Number of Products under Development by Companies, H2 2019

Number of Products under Development by Universities/Institutes, H2 2019

Number of Products by Targets, H2 2019

Number of Products by Stage and Targets, H2 2019

Number of Products by Routes of Administration, H2 2019

Number of Products by Stage and Routes of Administration, H2 2019

Number of Products by Top 10 Molecule Types, H2 2019

Number of Products by Stage and Top 10 Molecule Types, H2 2019

    Pricing

Discounts available for multiple report purchases.

reportstore@globalmarketsdirect.com
+44 (0) 161 359 5414

Saved reports